Announcing our Series B funding with thanks to our investors and customers!

Dear Readers,

I’m delighted to let you know that QPID Health has closed its Series B round of funding. The $12.3m round was led by New Leaf Venture Partners and joined by all investors who participated in the Series A round.  Proceeds will be used to accelerate the growth of our team and meet the demand from hospitals and practices to get clinical intelligence from the growing mass of digital patient data locked in EHRs. By “clinical intelligence” we mean the aspects of the patient’s history and status – including diagnoses, procedures, test results and potential safety concerns – that clinicians need to make the best decisions in the clinical trench, while avoiding the wasteful use of resources the comes from lack of access to information.

We are excited about the future of the company and look forward to the contribution of Philippe Chambon and his team at New Leaf, as well as the continued support of our initial investors. We are especially grateful to our customers who are true partners in innovation with QPID.

All of us members of the QPID team feel lucky to be able to contribute to improving healthcare in the U.S., and our funding gives us the means to accelerate our work.

Here’s the complete Press Release.

Let’s improve healthcare,

Mike

Mike Doyle, President & CEO
mike.doyle@qpidhealth.com

Share this story: